forbes top glp 1 companies How GLP-1 Weight Loss Drugs Have Revolutionized Obesity — Lessons Learned Forbes: The GLP-1 Economy Is

Microdosing was not part of those studies

Support HuffPost

REP has received consulting fees from Bayer, Corcept Therapeutics, Dexcom, Hanmi Pharmaceutical, Merck, Novo Nordisk, Pfizer, Sanofi, Scohia Pharma and Sun Pharmaceutical Industries, and grants/research support from Hanmi Pharmaceutical, Janssen, Metavention, Novo Nordisk, Poxel and Sanofi

Implementing utilization management strategies

Though we controlled for an extensive list of variables and the findings were replicated in two separate populations with different characteristics at two non-overlapping study periods, these limitations could not be fully eliminated